Rare condition

Malignant epithelial tumor of ovary

00

studies recruiting now

checking live

00

studies registered in total

checking live

00

countries with a recruiting site

checking live

00

recruiting study posted to date

checking live

Recruiting trials

Fetching live from ClinicalTrials.gov. This condition is not yet in our weekly snapshot; live results only.

Keep watching

Get an email when a new Malignant epithelial tumor of ovary study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

A group of conditions, not a single diagnosis

Orphanet classifies “Malignant epithelial tumor of ovary” as a category that groups several related conditions. Trials are usually registered under the specific condition, so the figures above may undercount. Browse the conditions in this group or see the classification on Orphanet.

Treatments being studied

1 approved treatment and 10 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Mirvetuximab Soravtansine (Elahere)
Phase 3Bevacizumab (Abevmy)
Phase 3Tamoxifen Citrate (Emblon)
Phase 3Thalidomide (Kevadon)
Phase 3Veliparib
Phase 2Tinzaparin
Phase 2Oregovomab (Ovarex)
Phase 2Sunitinib Malate (Sunitinib malate)
Phase 2Nibrozetone

+ 2 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).